We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > JSR

News List

JSR Life Sciences Unveils Corporate Venture Fund contractpharma
March 25, 2021
JSR Life Sciences LLC has launched the ‘JSR Life Sciences Corporate Venture Fund’ as part of a continued effort to identify and accelerate novel therapies and innovative technologies.
SpyBiotech Licenses Selexis’ SUREtechnology for HCMV Vax contractpharma
March 19, 2021
Selexis SA, a JSR Life Sciences company, and SpyBiotech, a biotechnology company with a novel vaccine platform, have signed a commercial license agreement to advance SPYVLP102, SpyBiotech’s lead vaccine program for human cytomegalovirus (HCMV).
CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing contractpharma
February 26, 2021
Crown Bioscience, JSR Life Sciences and Cambridge Quantum Computing (CQC) have entered a partnership agreement to explore the application of quantum technology to drive the identification of multi-gene biomarker discovery for oncology drug discovery.
JSR Life Sciences Snaps Up CRO in $400M Deal biospace
December 21, 2017
The parent company of JSR Life Sciences snapped up contract research organization Crown Bioscience International for $400 million, the company announced this morning.